Development of a Reproducible Prognostic Gene Signature to Predict the Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma

Alongside various clinical prognostic factors for diffuse large B-cell lymphoma (DLBCL) such as the international prognostic index (IPI) components (ie, age, tumor stage, performance status, serum lactate dehydrogenase concentration, and number of extranodal sites), prognostic gene signatures have r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamani-Ahmadmahmudi, Mohamad, Nassiri, Seyed Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704056/
https://www.ncbi.nlm.nih.gov/pubmed/31434961
http://dx.doi.org/10.1038/s41598-019-48721-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704056/
https://www.ncbi.nlm.nih.gov/pubmed/31434961
http://dx.doi.org/10.1038/s41598-019-48721-0

Ejemplares similares